Reengineering of Apheresis Donation Site and Workflow during COVID-19 Epidemic

doi:10.3969/j.issn.1671-2587.2020.03.005

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2020, Vol. 22 ›› Issue (3): 241-245.DOI: 10.3969/j.issn.1671-2587.2020.03.005

Previous Articles Next Articles

Reengineering of Apheresis Donation Site and Workflow during COVID-19 Epidemic

YE Sheng, SHEN Yan, CHEN Jin, et al

Nanjing Red Cross Blood Center, Nanjing 210003

Received:2020-03-18 Online:2020-06-20 Published:2020-06-13

Abstract

Abstract: Objective To reengineer apheresis donation site and workflow during COVID-19 epidemic to ensure the safety of blood donor and staff. Methods Adjusting donation workplace settings, blood donation process, disinfection and cleaning, and staff safety protection, etc., to establish a safe, reliable and effective apheresis donation place and workflow that meets the requirements for epidemic prevention and control. Results By adjusting donation workplace settings and process reengineering, enhancing COVID-19 consultation and post-donation interview, and strengthening safety protection and disinfection and cleaning operations at work, not only 1397 platelet doses of 745 person-times were collected, but also no donors or staffs were infected with COVID-19 during COVID-19 epidemic. Conclusion During COVID-19 epidemic, it is necessary to reengineer apheresis donation site and workflow to meet the dual needs of epidemic prevention and collection of platelet, and provide a strong safety guarantee for the orderly apheresis donation work during COVID-19 epidemic.

Key words: COVID-19, Apheresis donation, Workflow reengineering, Disinfection, Safety protection

CLC Number:

R197.6

YE Sheng, SHEN Yan, CHEN Jin, et al. Reengineering of Apheresis Donation Site and Workflow during COVID-19 Epidemic[J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(3): 241-245.

References

[1] 国家卫生健康委办公厅,国家中医药管理局办公室.新型冠状病毒肺炎诊疗方案(试行第六版)[J].中国感染控制杂志,2020,19(2):192-195.
[2] 蔡艳,李亚茹,刘丽娟,等.应用MCS+LDP和UPP程序单采血小板的效果对比分析[J].中国输血杂志,2019,32(8):826-828.
[3] 中华人民共和国国家卫生健康委员会.医疗机构消毒技术规范[EB/OL].(2012-04-05) .http://www.nhc.gov.cn/wjw/s9496/201204/54510.shtml.
[4] 中华人民共和国国家卫生健康委员会.公共场所新型冠状病毒感染的肺炎卫生防护指南 [EB/OL].(2020-01-30).http://www.nhc.gov.cn/jkj/s7916/202001/d9ae8301384a4239a8041d6f77da09b6.shtml.
[5] 中华人民共和国国家卫生健康委员会.新型冠状病毒肺炎防控方案(第五版) [EB/OL].(2020-02-21).http://www.nhc.gov.cn/xcs/zhengcwj/202002/a5d6f7b8c48c451c87dba14889b30147.shtml.
[6] 中国输血协会临床输血管理学委员会. 2019新型冠状病毒肺炎防控期间临床输血血型血清学实验室生物安全防护指南(第二版)[J/OL].临床输血与检验: 1-5(2020-03-25).http://kns.cnki.net/kcms/detail/34.1239.r.20200319.1812.004.html.
[7] Zhou P,Yang X L,Wang X G,et al.A Pneumonia Outbreak Associated with A New Coronavirus of Probable Bat Origin[J]. Nature, 2020, 579(7798):270-273.
[8] 中国输血协会.T/CSBT 005-2019血站业务场所建设指南第1部分:单采[S].2019-04-12.
[9] 中华人民共和国国家卫生健康委员会.新型冠状病毒肺炎防控方案(第六版)[EB/OL].(2020-03-07).http://www.nhc.gov.cn/xcs/zhengcwj/202003/4856d5b0458141fa9f376853224d41d7.shtml.
[10] 中国输血协会.关于新型冠状病毒疫情防控期间采供血工作的若干工作建议(第一版)[EB/OL].(2020-02-05). https://www.csbt.org.cn/plus/view.php?aid=16530.
[11] 中华人民共和国国家卫生健康委员会.新型冠状病毒肺炎诊疗方案(试行第七版) [EB/OL].(2020-03-04).http://www.nhc.gov.cn/xcs/zhengcwj/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml.
[12] 温绣蔺,李洁琼,霍晓薇,等. 人员活动对动态空气消毒机病室空气消毒效果的影响[J]. 护理学杂志,2015,30(19):54-56.
[13] The American Association of Blood Banks. Update: Impact of 2019 Novel Coronavirus and Blood Safety[EB/OL].(2020-02-25).http://www.aabb.org/advocacy/regulatorygovernment/Documents/Impact-of-2019-Novel-Coronavirus-on-Blood-Donation.pdf
[14] Asia Pacific Blood Network.2019 Novel Coronavirus (SARS-CoV-2);Expected challenges and risks to blood safety[EB/OL].(2020-02-17).https://apbnonline.com/images/apbn%20rapid%20brief%20white%20paper%202019%20novel%20coronavirus%20sars-cov-2.pdf

Reengineering of Apheresis Donation Site and Workflow during COVID-19 Epidemic

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 6

Recommended Articles

Metrics

Comments

About

Author

Journal

Access Statistics

Contact

[1]	TANG Zong-sheng. Strategies to Enhance the Care and Privacy of Plasma Donors during COVID-19 Rehabilitation and Their Significance [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(5): 458-461.
[2]	XIE Yu-bin, ZOU Bin-bin, CHEN Dong, et al.. Analysis of Health Status and Antibody Level of COVID-19 Convalescent Plasma Donors [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(4): 343-348.
[3]	WANG Yun, ZHAO Chang-cheng, GU Yan, et al.. Analysis of Novel Coronavirus Pneumonia Related Blood Test Indexes in 80 Cases [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(4): 360-366.
[4]	Chinese Society of Blood Transfusion Clinical Transfusion Management Committee. Investigation and Analysis of Biosafety Protection of Blood Transfusion Departments (Blood Banks) in 2 309 Hospitals during the Epidemic Situation of Novel Coronavirus Pneumonia [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(3): 249-252.
[5]	YING Shang-yun, ZHAO Yi-lun, YUAN Yong, et al. Strategies for the Prevention and Control of Emergency Group Blood Donation Sites during the COVID-19 Pandemic [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(3): 253-258.
[6]	HUANG Qiong, XU Yun-yun, LIU Hai-yan, et al. Study on the Correlation between IgM Antibody and Bloodcell Count and C-reactive Protein in Patients with COVID-19 Convalescent Plasma [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(3): 322-325.